De novo design of self-assembling foldamers that inhibit heparin-protein interactions

Geronda L. Montalvo, Yao Zhang, Trevor M. Young, Michael J. Costanzo, Katie B. Freeman, Jun Wang, Dylan J. Clements, Emma Magavern, Robert W. Kavash, Richard W. Scott, Dahui Liu, William F. Degrado

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

A series of self-associating foldamers have been designed as heparin reversal agents, as antidotes to prevent bleeding due to this potent antithrombotic agent. The foldamers have a repeating sequence of Lys-Sal, in which Sal is 5-amino-2-methoxy-benzoic acid. These foldamers are designed to self-associate along one face of an extended chain in a -sheet-like interaction. The methoxy groups were included to form intramolecular hydrogen bonds that preclude the formation of very large amyloid-like aggregates, while the positively charged Lys side chains were introduced to interact electrostatically with the highly anionic heparin polymer. The prototype compound (Lys-Sal) 4 carboxamide weakly associates in aqueous solution at physiological salt concentration in a monomer-dimer-hexamer equilibrium. The association is greatly enhanced at either high ionic strength or in the presence of a heparin derivative, which is bound tightly. Variants of this foldamer are active in an antithrombin III-factor Xa assay, showing their potential as heparin reversal agents.

Original languageEnglish (US)
Pages (from-to)967-975
Number of pages9
JournalACS Chemical Biology
Volume9
Issue number4
DOIs
StatePublished - Apr 18 2014
Externally publishedYes

Fingerprint

Heparin
Proteins
Antidotes
Factor Xa
Benzoic Acid
Fibrinolytic Agents
Antithrombin III
Ionic strength
Amyloid
Dimers
Osmolar Concentration
Hydrogen
Assays
Hydrogen bonds
Polymers
Salts
Monomers
Association reactions
Hemorrhage
Derivatives

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Montalvo, G. L., Zhang, Y., Young, T. M., Costanzo, M. J., Freeman, K. B., Wang, J., ... Degrado, W. F. (2014). De novo design of self-assembling foldamers that inhibit heparin-protein interactions. ACS Chemical Biology, 9(4), 967-975. https://doi.org/10.1021/cb500026x

De novo design of self-assembling foldamers that inhibit heparin-protein interactions. / Montalvo, Geronda L.; Zhang, Yao; Young, Trevor M.; Costanzo, Michael J.; Freeman, Katie B.; Wang, Jun; Clements, Dylan J.; Magavern, Emma; Kavash, Robert W.; Scott, Richard W.; Liu, Dahui; Degrado, William F.

In: ACS Chemical Biology, Vol. 9, No. 4, 18.04.2014, p. 967-975.

Research output: Contribution to journalArticle

Montalvo, GL, Zhang, Y, Young, TM, Costanzo, MJ, Freeman, KB, Wang, J, Clements, DJ, Magavern, E, Kavash, RW, Scott, RW, Liu, D & Degrado, WF 2014, 'De novo design of self-assembling foldamers that inhibit heparin-protein interactions', ACS Chemical Biology, vol. 9, no. 4, pp. 967-975. https://doi.org/10.1021/cb500026x
Montalvo, Geronda L. ; Zhang, Yao ; Young, Trevor M. ; Costanzo, Michael J. ; Freeman, Katie B. ; Wang, Jun ; Clements, Dylan J. ; Magavern, Emma ; Kavash, Robert W. ; Scott, Richard W. ; Liu, Dahui ; Degrado, William F. / De novo design of self-assembling foldamers that inhibit heparin-protein interactions. In: ACS Chemical Biology. 2014 ; Vol. 9, No. 4. pp. 967-975.
@article{196f166109764b01a88d77c40ba7b844,
title = "De novo design of self-assembling foldamers that inhibit heparin-protein interactions",
abstract = "A series of self-associating foldamers have been designed as heparin reversal agents, as antidotes to prevent bleeding due to this potent antithrombotic agent. The foldamers have a repeating sequence of Lys-Sal, in which Sal is 5-amino-2-methoxy-benzoic acid. These foldamers are designed to self-associate along one face of an extended chain in a -sheet-like interaction. The methoxy groups were included to form intramolecular hydrogen bonds that preclude the formation of very large amyloid-like aggregates, while the positively charged Lys side chains were introduced to interact electrostatically with the highly anionic heparin polymer. The prototype compound (Lys-Sal) 4 carboxamide weakly associates in aqueous solution at physiological salt concentration in a monomer-dimer-hexamer equilibrium. The association is greatly enhanced at either high ionic strength or in the presence of a heparin derivative, which is bound tightly. Variants of this foldamer are active in an antithrombin III-factor Xa assay, showing their potential as heparin reversal agents.",
author = "Montalvo, {Geronda L.} and Yao Zhang and Young, {Trevor M.} and Costanzo, {Michael J.} and Freeman, {Katie B.} and Jun Wang and Clements, {Dylan J.} and Emma Magavern and Kavash, {Robert W.} and Scott, {Richard W.} and Dahui Liu and Degrado, {William F.}",
year = "2014",
month = "4",
day = "18",
doi = "10.1021/cb500026x",
language = "English (US)",
volume = "9",
pages = "967--975",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - De novo design of self-assembling foldamers that inhibit heparin-protein interactions

AU - Montalvo, Geronda L.

AU - Zhang, Yao

AU - Young, Trevor M.

AU - Costanzo, Michael J.

AU - Freeman, Katie B.

AU - Wang, Jun

AU - Clements, Dylan J.

AU - Magavern, Emma

AU - Kavash, Robert W.

AU - Scott, Richard W.

AU - Liu, Dahui

AU - Degrado, William F.

PY - 2014/4/18

Y1 - 2014/4/18

N2 - A series of self-associating foldamers have been designed as heparin reversal agents, as antidotes to prevent bleeding due to this potent antithrombotic agent. The foldamers have a repeating sequence of Lys-Sal, in which Sal is 5-amino-2-methoxy-benzoic acid. These foldamers are designed to self-associate along one face of an extended chain in a -sheet-like interaction. The methoxy groups were included to form intramolecular hydrogen bonds that preclude the formation of very large amyloid-like aggregates, while the positively charged Lys side chains were introduced to interact electrostatically with the highly anionic heparin polymer. The prototype compound (Lys-Sal) 4 carboxamide weakly associates in aqueous solution at physiological salt concentration in a monomer-dimer-hexamer equilibrium. The association is greatly enhanced at either high ionic strength or in the presence of a heparin derivative, which is bound tightly. Variants of this foldamer are active in an antithrombin III-factor Xa assay, showing their potential as heparin reversal agents.

AB - A series of self-associating foldamers have been designed as heparin reversal agents, as antidotes to prevent bleeding due to this potent antithrombotic agent. The foldamers have a repeating sequence of Lys-Sal, in which Sal is 5-amino-2-methoxy-benzoic acid. These foldamers are designed to self-associate along one face of an extended chain in a -sheet-like interaction. The methoxy groups were included to form intramolecular hydrogen bonds that preclude the formation of very large amyloid-like aggregates, while the positively charged Lys side chains were introduced to interact electrostatically with the highly anionic heparin polymer. The prototype compound (Lys-Sal) 4 carboxamide weakly associates in aqueous solution at physiological salt concentration in a monomer-dimer-hexamer equilibrium. The association is greatly enhanced at either high ionic strength or in the presence of a heparin derivative, which is bound tightly. Variants of this foldamer are active in an antithrombin III-factor Xa assay, showing their potential as heparin reversal agents.

UR - http://www.scopus.com/inward/record.url?scp=84899072740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899072740&partnerID=8YFLogxK

U2 - 10.1021/cb500026x

DO - 10.1021/cb500026x

M3 - Article

C2 - 24491145

AN - SCOPUS:84899072740

VL - 9

SP - 967

EP - 975

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 4

ER -